Year after year we are seeing an alarming increase in the number of people getting obese and contracting chronic lifestyle diseases such as diabetes. In fact, as per a rather interesting report released recently by a UK-based medical journal, The Lancet, it is for the first time since modern institutions started collating health-related data that the world has more obese people than malnourished.
The condition is worrisome, particularly in the UAE where 19 per cent of the population, or over a million people, is diabetic. Globally, the number of diabetic patients has quadrupled in the last four decades. Data from the World Health Organisation (WHO) shows that 422 million people are known to be living with the disease, and by 2040, the figure would rise to 642 million. Industry experts also suggest that there are 318 million more people who are pre-diabetic, and their population is expected to grow to 481 million by 2040.
The news about type 2 diabetes and its impact on seniors can be quite scary. But the reality is that this disease is highly preventable, which is my focus in this article.
But before I get to how diabetes is preventable in many seniors, I feel it is important to mention some very important – and sobering – statistics. According to the American Diabetes Association, approximately 25 percent of Americans over the age of 60 have type 2 diabetes. And according to the Centers for Disease Control and Prevention, 50 percent of those over the age of 65 are pre-diabetic – but only 7 percent even know they are.
When it comes to diabetes and its prevention, knowledge is certainly power and powerful.
What is diabetes and why are seniors more apt to develop it?
AeroFlow Healthcare celebrated their latest opening in Greenwood South Carolina
Aeroflow Healthcare is recognized as a premier provider of durable medical equipment (DME) and service in the Southeast, and continues to grow nationwide. We pride ourselves on offering quality equipment and the best in personal customer service.
Patients and physicians nationwide are choosing Aeroflow as their provider for home oxygen, diagnostic sleep testing, CPAP equipment and supplies, nebulizers, mobility equipment, breastpumps, pediatric needs, catheters, negative pressure wound therapy and more. Aeroflow Healthcare is located at 105 Vine Crest Court in Greenwood SC.
Sanity G6 NPWT pump rental is a negative pressure wound therapy pump, and does not use an internal air pump to provide vacuum to a collection canister. The Sanity G6 instead has a patented vacuum pump that is integrated with a canister.
The tubing is permanently attached and a venting system keeps the tubing clear.
The pump is FDA-listed and PDAC-approved. It can run for up to 30 hours.
It can be used with Nurse Rosie’s GelTex NPWT Black Foam Kits, LipoGel or IodoFoam.
WiseGuyReports.com adds “Negative Pressure Wound Therapy – Medical Devices Pipeline Assessment 2016” report to its research database.
GlobalData’s Medical Devices sector report, “Negative Pressure Wound Therapy (NPWT) – Medical Devices Pipeline Assessment, 2016″ provides an overview of Negative Pressure Wound Therapy (NPWT) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Negative Pressure Wound Therapy (NPWT) pipeline products.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
– Extensive coverage of the Negative Pressure Wound Therapy (NPWT) under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Negative Pressure Wound Therapy (NPWT) and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to buy
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Negative Pressure Wound Therapy (NPWT) under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
San Antonio Thursday, April 14, 2016, 17:00 Hrs [IST]
Acelity, a global advanced wound care and regenerative medicine company, announced that its TIELLE Foam Dressing Family is now available in the United States. The TIELLE Dressing Family expands the industry-leading advanced wound therapeutics portfolio from Acelity. This expansion complements a broad range of existing solutions for chronic and acute wounds and provides clinicians with efficient and cost-effective options for treating patients.
The company announced the availability of these products at the joint meeting of the Symposium of Advanced Wound Care and the Wound Healing Society (SAWC Spring/WHS) in Atlanta.
“Our goal was to reinvigorate the range of proven TIELLE Dressings and introduce it to clinicians here in the US who are seeking effective solutions for all patients, including the most compromised,” said Joe Woody, president and chief executive officer of Acelity. “We aim to strengthen our partnership with nurses and physicians by broadening our platform to include an extensive range of dressings, advancements in negative pressure technology and new innovations designed to help speed healing for patients and reduce the overall cost of care.”
The TIELLE Foam Dressing Family was designed to meet the needs of healthcare professionals, including exudate management and reduced pain for the patient at dressing removal.
The TIELLE Hydropolymer Dressings – TIELLE Silicone Border and TIELLE Non-Adhesive – include the unique LIQUALOCK Advanced Absorption Technology which locks fluid away to help prevent leakage and maceration. Both dressings are intended to manage a range of exudate levels in partial or full thickness wounds. They are designed to help maintain a moist wound healing environment through the combination of fluid absorption and moisture vapor transfer rate (MVTR), and to be worn for up to seven days depending on the wound condition and exudate levels, which may help reduce the number of dressing changes and associated cost, a benefit for patients, payors and providers.
TIELLE Silicone Border is intended to manage a range of exudate levels in partial or full thickness wounds. The soft silicone adhesive spans the full extent of the dressing, allowing for gentle removal, helping to minimise pain and trauma for the patient.
TIELLE Non-Adhesive is a low profile dressing, which supports patient comfort and may be cut to size.
TIELLE ESSENTIAL Foam Dressings provide a range of economical foam dressings designed to absorb moderate to heavy exudate, maintaining a moist healing environment to aid in the healing process for chronic and acute wounds. The range of new available dressings includes: TIELLE ESSENTIAL Non-Adhesive and Heel; TIELLE ESSENTIAL Border; TIELLE ESSENTIAL Silicone Border; TIELLE ESSENTIAL Silicone Border Sacrum; TIELLE ESSENTIAL Silicone
“Acelity will continue to strengthen our portfolio of wound care and regenerative medicine products to provide clinicians the most options at every step of the care continuum – from the O.R., to the hospital room and at home,” said Woody.
Systagenix, an Acelity company, introduced the TIELLE Hydropolymer Dressing range in Europe in 1992. In 2013, KCI commercialised Negative Pressure Wound Therapy with the introduction of the V.A.C. Therapy System in 1995 and then strengthened its position in the global wound therapeutics industry by acquiring Systagenix in 2012, increasing the company’s ability to offer best-in-class products across the wound care continuum. In 2014, KCI, Systagenix, and LifeCell, a developer of tissue repair products, combined to form Acelity, a global corporation devoted to the art and science of healing.
Simplified negative pressure wound therapy systems can provide healing results comparable to more complex systems, a new study shows.
Some advanced NPWT Rental systems are too complex for routine use and are not cost- effective for many healthcare providers, according to investigators from Brazil’s Bahia State General Hospital.
Researchers treated patients with difficult-to-manage wounds using a “simplified” NPWT REntal system that’s quieter, easier to use and more widely available than the “gold standard” systems, they said.
Healing of the wounds treated with the simplified system was found to be satisfactory in 87% of the cases, and had low complication rates.
Those results show promise for healthcare facilities with limited resources or fewer trained staff members, researchers said.
Report includes top line data relating on Negative Pressure Wound Therapy (NPWT Rental) Global clinical trials scenario.
This report on Negative Pressure Wound Therapy (NPWT) also includes an review of trial numbers as well as their ( Negative Pressure Wound Therapy (NPWT) ) average enrollment in uppermost/top countries which are conducted worldwide.
Negative Pressure Wound Therapy (NPWT) report also covers disease clinical trials by country (G7 & E7), sponsor type, region, trial status as well as end points status.
Report Negative Pressure Wound Therapy (NPWT) also Includes prominent drugs for in-progress trials (Note: based on number of ongoing trials).
Scope of Negative Pressure Wound Therapy (NPWT) Report:-
1. This report includes a snapshot of worldwide clinical trials landscape on Negative Pressure Wound Therapy (NPWT) scenario.
2. Report on Negative Pressure Wound Therapy (NPWT) also provides top level data related to the Global clinical trials by country (G7 & E7), sponsor type, region, trial status as well as end points status on Negative Pressure Wound Therapy (NPWT) scenario
3. Report reviews top companies involved in Negative Pressure Wound Therapy (NPWT) as well as provides enlists all trials (Trial title, Phase, and Status) pertaining to the company on Negative Pressure Wound Therapy (NPWT) scenario.
4. This report provides all the unaccomplished trials on Negative Pressure Wound Therapy (NPWT) scenario (Withdrawn, Terminated and Suspended) with reason for unaccomplishment on Negative Pressure Wound Therapy (NPWT) .
5. Report on Negative Pressure Wound Therapy (NPWT) provides enrollment trends for the past five years.
6. Report provides latest news for the past three months
7. Report Also Includes Top news in past 3 months on Negative Pressure Wound Therapy (NPWT) clinical trials review scenario.
Market Research Store is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.